Literature DB >> 21508164

Comparative study of immune status to infectious agents in elderly patients with multiple myeloma, Waldenstrom's macroglobulinemia, and monoclonal gammopathy of undetermined significance.

Johanna Karlsson1, Björn Andréasson, Nahid Kondori, Evelina Erman, Kristian Riesbeck, Harriet Hogevik, Christine Wennerås.   

Abstract

Whereas patients with multiple myeloma (MM) have a well-documented susceptibility to infections, this has been less studied in other B-cell disorders, such as Waldenstrom's macroglobulinemia (WM) and monoclonal gammopathy of undetermined significance (MGUS). We investigated the humoral immunity to 24 different pathogens in elderly patients with MM (n = 25), WM (n = 16), and MGUS (n = 18) and in age-matched controls (n = 20). Antibody titers against pneumococci, staphylococcal alpha-toxin, tetanus and diphtheria toxoids, and varicella, mumps, and rubella viruses were most depressed in MM patients, next to lowest in WM and MGUS patients, and highest in the controls. In contrast, levels of antibodies specific for staphylococcal teichoic acid, Moraxella catarrhalis, candida, aspergillus, and measles virus were similarly decreased in MM and MGUS patients. Comparable titers in all study groups were seen against Haemophilus influenzae type b (Hib), borrelia, toxoplasma, and members of the herpesvirus family. Finally, a uniform lack of antibodies was noted against Streptococcus pyogenes, salmonella, yersinia, brucella, francisella, and herpes simplex virus type 2. To conclude, although MM patients displayed the most depressed humoral immunity, significantly decreased antibody levels were also evident in patients with WM and MGUS, particularly against Staphylococcus aureus, pneumococci, and varicella. Conversely, immunity was retained for Hib and certain herpesviruses in all study groups.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21508164      PMCID: PMC3122605          DOI: 10.1128/CVI.00021-11

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  35 in total

Review 1.  Induced humoral immunity and vaccination against major human fungal pathogens.

Authors:  Arturo Casadevall; Marta Feldmesser; Liise-anne Pirofski
Journal:  Curr Opin Microbiol       Date:  2002-08       Impact factor: 7.934

2.  Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants.

Authors:  Atsuko Hata; Hideomi Asanuma; Mary Rinki; Margaret Sharp; Ruby M Wong; Karl Blume; Ann M Arvin
Journal:  N Engl J Med       Date:  2002-07-04       Impact factor: 91.245

3.  Antibody assays for varicella-zoster virus: comparison of enzyme immunoassay with neutralization, immune adherence hemagglutination, and complement fixation.

Authors:  B Forghani; N J Schmidt; J Dennis
Journal:  J Clin Microbiol       Date:  1978-11       Impact factor: 5.948

Review 4.  Ageing and infection.

Authors:  Gaëtan Gavazzi; Karl-Heinz Krause
Journal:  Lancet Infect Dis       Date:  2002-11       Impact factor: 25.071

5.  Antibody responses in patients with invasive Staphylococcus aureus infections.

Authors:  G Jacobsson; P Colque-Navarro; E Gustafsson; R Andersson; R Möllby
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-04-10       Impact factor: 3.267

6.  Levels of antibodies specific to tetanus toxoid, Haemophilus influenzae type b, and pneumococcal capsular polysaccharide in healthy children and adults.

Authors:  Uwe Schauer; Frank Stemberg; Christian H L Rieger; Wolfgang Büttner; Michael Borte; Simone Schubert; Helga Möllers; Frank Riedel; Udo Herz; Harald Renz; Wilhelm Herzog
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

7.  Microagglutination procedures for febrile agglutination tests.

Authors:  J B Gaultney; R D Wende; R P Williams
Journal:  Appl Microbiol       Date:  1971-10

Review 8.  Waldenström macroglobulinaemia: presenting features and outcome in a series with 217 cases.

Authors:  R García-Sanz; S Montoto; A Torrequebrada; A G de Coca; J Petit; A Sureda; J A Rodríguez-García; P Massó; A Pérez-Aliaga; M D Monteagudo; I Navarro; G Moreno; C Toledo; A Alonso; C Besses; J Besalduch; I Jarque; P Salama; J A Rivas; B Navarro; J Bladé; J F Miguel
Journal:  Br J Haematol       Date:  2001-12       Impact factor: 6.998

9.  Evaluation of solubilized herpes simplex virus membrane antigen by enzyme-linked immunosorbent assay.

Authors:  S Jeansson; M Forsgren; B Svennerholm
Journal:  J Clin Microbiol       Date:  1983-11       Impact factor: 5.948

10.  Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma.

Authors:  J D Robertson; K Nagesh; S N Jowitt; M Dougal; H Anderson; K Mutton; M Zambon; J H Scarffe
Journal:  Br J Cancer       Date:  2000-04       Impact factor: 7.640

View more
  30 in total

Review 1.  The dawn of vaccines for cancer prevention.

Authors:  Olivera J Finn
Journal:  Nat Rev Immunol       Date:  2017-12-27       Impact factor: 53.106

2.  Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients.

Authors:  Cecilie Blimark; Erik Holmberg; Ulf-Henrik Mellqvist; Ola Landgren; Magnus Björkholm; Malin Hultcrantz; Christian Kjellander; Ingemar Turesson; Sigurdur Y Kristinsson
Journal:  Haematologica       Date:  2014-10-24       Impact factor: 9.941

3.  Risk of invasive Haemophilus influenzae type b (Hib) disease in adults with secondary immunodeficiency in the post-Hib vaccine era.

Authors:  Eli B Nix; Nicole Hawdon; Sean Gravelle; Birubi Biman; Malcolm Brigden; Saleem Malik; William McCready; Garry Ferroni; Marina Ulanova
Journal:  Clin Vaccine Immunol       Date:  2012-03-07

4.  Pathogen-Specific Humoral Immunity and Infections in B Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy Recipients with Multiple Myeloma.

Authors:  Srirama Josyula; Margot J Pont; Sayan Dasgupta; Xiaoling Song; Sushma Thomas; Gregory Pepper; Jacob Keane-Candib; Terry L Stevens-Ayers; Hans D Ochs; Michael J Boeckh; Stanley R Riddell; Andrew J Cowan; Elizabeth M Krantz; Damian J Green; Joshua A Hill
Journal:  Transplant Cell Ther       Date:  2022-03-11

Review 5.  What is the significance of monoclonal gammopathy of undetermined significance?

Authors:  Catherine Atkin; Alex Richter; Elizabeth Sapey
Journal:  Clin Med (Lond)       Date:  2018-10       Impact factor: 2.659

6.  Common community-acquired infections and subsequent risk of multiple myeloma: a population-based study.

Authors:  Charlene M McShane; Liam J Murray; Eric A Engels; Ola Landgren; Lesley A Anderson
Journal:  Int J Cancer       Date:  2013-10-12       Impact factor: 7.396

7.  Antibodies against vaccine-preventable infections after CAR-T cell therapy for B cell malignancies.

Authors:  Carla S Walti; Elizabeth M Krantz; Joyce Maalouf; Jim Boonyaratanakornkit; Jacob Keane-Candib; Laurel Joncas-Schronce; Terry Stevens-Ayers; Sayan Dasgupta; Justin J Taylor; Alexandre V Hirayama; Merav Bar; Rebecca A Gardner; Andrew J Cowan; Damian J Green; Michael J Boeckh; David G Maloney; Cameron J Turtle; Joshua A Hill
Journal:  JCI Insight       Date:  2021-06-08

8.  Clinical course and management of postoperative methicillin-resistant Staphylococcus aureus keratitis in immunocompromised patients: two case reports.

Authors:  Timothy Y Chou; Sujata P Prabhu
Journal:  Clin Ophthalmol       Date:  2011-12-20

9.  Community-acquired infections associated with increased risk of lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia.

Authors:  Charlene M McShane; Liam J Murray; Eric A Engels; Lesley A Anderson
Journal:  Br J Haematol       Date:  2013-11-26       Impact factor: 6.998

10.  Cause-specific mortality in individuals with lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia, 2000-2016.

Authors:  Nicole H Dalal; Graça M Dores; Rochelle E Curtis; Martha S Linet; Lindsay M Morton
Journal:  Br J Haematol       Date:  2020-02-23       Impact factor: 8.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.